I N T R O D U C T I O N
Malnutrition and inflammation are highly prevalent and intimately linked conditions in chronic kidney disease (CKD) patients [1] [2] [3] . While malnutrition may predispose to inflammatory states [4] , inflammation may induce abnormalities in nutritional status also in patients with adequate nourishment [1] . The state of decreased body stores of protein and energy that follows as a result of these two conditions has been termed protein-energy wasting (PEW) [1] .
Various clinical, nutritional and biochemical parameters are being used to diagnose and grade PEW in individuals with kidney disease. Among nutritional scoring systems, the Subjective Global Assessment (SGA) and the Malnutrition-Inflammation Score (MIS) are often employed [1] . MIS is a specific adaptation of the SGA questionnaire for hemodialysis (HD) patients proposed by Kalantar-Zadeh et al. [5] . MIS converts SGA into a semiquantitative scoring system by adding some objective clinical and laboratorial markers of relevance in CKD. MIS has been validated against other nutritional/inflammatory biomarkers and has been found to be associated with poor outcomes in patients receiving HD [5, 6] , peritoneal dialysis [7, 8] and kidney transplantation [9] . MIS could be a valid nutritional assessment tool in nondialyzed CKD patients; however, to the best of our knowledge, no study has to date analyzed the diagnostic and prognostic validity of MIS in this patient population. Here, we sought to validate MIS as a surrogate marker of PEW by testing its association with markers of inflammation and nutritional status, as well as to evaluate its mortality predictive capacity in a relatively large well-characterized cohort of nondialyzed CKD patients.
M AT E R I A L S A N D M E T H O D S
Patients and study design This study is an ancillary analysis of the Malnutrition, Inflammation and Vascular Calcification (MIVC) cohort which was established to evaluate associations between traditional, novel and uremic risk factors with cardiovascular and general morbimortality in CKD patients [10, 11] . MIVC comprises 300 consecutive nondialyzed CKD stages 3-5 patients {median age of 61 [interquartile range (IQR) 53-68] years; 63% men; 57% current or former smokers} recruited at the outpatient clinic of the Hypertension and Nephrology Division at Dante Pazzanese Institute of Cardiology in Sao Paulo, Brazil. Recruitment took place between March 2010 and March 2013 and included patients referred to begin nephrologic assessment. Thus, the majority of them had not yet received pharmacological treatment or dietary therapy at the time of evaluation. Exclusion criteria were age below 18 and above 80 years, clinical signs of acute infection during the month preceding the inclusion, active cancer or liver disease at the time of evaluation, previous diagnosis of immunological diseases and unwillingness to participate in the study. CKD was defined as a glomerular filtration rate (GFR) <60 mL/min/ 1.73 m 2 based on the Modification of Diet in Renal Disease (MDRD) equation: GFR = 186 × (serum creatinine) −1.154 × (Age) −0.203 × (0.742 if female) × (1.210 if black). A single physician (A.C.C.) performed a complete chart review and interviewed patients regarding their clinical history. The patients were followed from the day of inclusion, and mortality dates was recorded. There was no loss of follow-up of any patient. The Ethics Committee at Dante Pazzanese Institute of Cardiology approved the study and informed consent was obtained from each patient.
Anthropometry, body composition, dietary intake, blood pressure and comorbidities Anthropometric parameters included body weight, height, body mass index (BMI; body weight divided by squared height) and waist circumference (at midway between the lowest lateral border of the ribs and the uppermost lateral iliac crest). Fat mass and lean body mass were assessed according to Durnin et al. [12] by skinfold thicknesses at four locations (biceps, triceps, subscapular and suprailiac) measured with a Harpenden skinfold caliper. Fat mass index and lean body mass index (LBMI) were calculated according to the method of Kyle et al. [13] and expressed as kg/m 2 . The mid-arm muscle circumference (MAMC) was derived from the triceps skinfold thickness (TSF) and mid-arm circumference (MAC) as follows: MAMC = MAC − (π × TSF); these measurements were performed on the dominant arm. Body cell mass (BCM) and phase angle were evaluated by bioelectrical impedance analysis (Biodynamics BIA 450 Bioimpedance Analyzer ® ) at the recruitment. Evaluation of handgrip strength (HGS) was performed on the dominant hand, using a manual dynamometer (Baseline ® Hydraulic Hand Dynamometer, NexGen Ergonomics, Inc., Quebec, Canada). After becoming familiarized with the device, patients were investigated standing with both arms extended sideways from the body with the dynamometer facing away from the body, and were instructed to grip the dynamometer with maximum strength in response to a voice command. The measurements were repeated three times and the highest value was noted for the study. A dietary recall was performed in all patients by a single nutritionist (F.C.A.). Blood pressure (BP) measurements were performed in the upper arm with a digital sphygmomanometer (HEM-705CP; Omron Healthcare, Inc., IL, USA). The measurements were repeated three times, according to the recommendations of the JNC7 report [14] , and the mean of the two last measurements was used. Mean arterial BP was calculated by the formula [(2 × diastolic BP) + systolic BP]/3. History of comorbidities were calculated by the Charlson comorbidity index [15] , which assigns 1 point for history of myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease (transient ischemic attack or cerebrovascular accident with minor or no residua), dementia, chronic pulmonary disease, connective tissue disorder, peptic ulcer disease, mild liver disease and diabetes without end-organ damage; 2 points for hemiplegia, moderate-to-severe renal disease, diabetes with end-organ damage, tumor without metastases, leukemia, lymphoma and myeloma; 3 points for moderate or severe liver disease and 6 points for metastatic solid tumor or acquired immune deficiency syndrome (AIDS). For every decade over 40 years of age, 1 point is added to the score. For the purposes of the present study, all patients received a score of 2 points for the presence of renal disease. There were no patients with connective tissue disorders, AIDS and/or malignant neoplasm.
Malnutrition-Inflammation Score MIS is a scoring system for assessment of malnutrition and inflammation [5] . MIS has 10 components derived from medical history, physical examination, BMI and laboratory parameters. Each score component is classified according to four levels of severity, from 0 (normal) to 3 (severely abnormal). The sum of all 10 MIS components ranges from 0 (normal) to 30 (severe degree of malnutrition and inflammation status). For the present analysis, and given the nature of the included patients, we excluded dialysis vintage from the score. Thus, comorbidity was scored as 0 if there were no other medical illnesses present; as Score 1 for mild comorbidity, excluding such major comorbid conditions as congestive heart failure class III or IV, severe coronary artery diseases, moderate-to-severe chronic obstructive pulmonary disease or major neurological sequels; as score of 2 for moderate comorbidity (including one of the diseases listed under major comorbid conditions) and as score of 3 for two or more major comorbid conditions. Furthermore, serum transferrin was used instead of total iron binding capacity. Thus, serum transferrin was scored as 0 ≥ 200 mg/dL; Score 1, 170-199 mg/dL; Score 2, 140-169 mg/dL and Score 3, <140 mg/dL. All subjective MIS assessments were done by the same physician (A.C.C.).
Laboratory parameters
Morning blood samples were taken after an overnight fast for generation of plasma and serum which were stored at −70°C, if not analyzed immediately. Parathyroid hormone (PTH) and ferritin were measured by chemiluminescence, plasma '25-hydroxy-vitamin D' by high-performance liquid chromatography [16] and serum leptin by a commercial ELISA kit (LDN, Nordhorn, Germany). Transferrin, alpha-1 acid glycoprotein (a1-AGP) and high-sensitivity C-reactive protein (CRP) were measured by immuno-turbidimetry, albumin was measured by colorimetry and fibrinogen by a modified Clauss assay [17] . 24-h urinary albumin excretion was analyzed by turbidimetry. Normalized protein nitrogen appearance (nPNA) was calculated according to the equation proposed by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative clinical practice guideline [18] . Circulating levels of hemoglobin, total cholesterol, high-density lipoprotein cholesterol, triglycerides and creatinine were analyzed using certified methods at the Department of Laboratory Medicine at Dante Pazzanese Institute of Cardiology.
Statistical analysis
The variables were expressed as mean ± SD, median (interquartile range, IQR) or as percentage, as appropriate. As many values were not normally distributed Spearman's rank correlation (Rho) was used to determine correlations. Differences between groups were compared by Kruskal-Wallis test or χ 2 analysis, as appropriate. Structural equation modeling with the asymptotically distribution free method was used to test goodness of fit of 1-and 2-factor models describing the relationship of malnutrition (defined by BIA-assessed BCM, muscle atrophy and leptin) and inflammation (defined by CRP and fibrinogen) with MIS. Model X 2 , also called discrepancy, the most commonly used fit test indicating that the theoretical model fits the given data, was used. A range of goodnessof-fit statistics also was computed for model comparison. The goodness-of-fit index, adjusted goodness-of-fit index and Bentler Comparative Fit index increase to a maximum of 1.00 when there is perfect fit. Values around 0.95 indicate a good fit. Root mean square error of approximation is a measure that penalizes for lack of parsimony in the model, which is useful because more complex models produce better fit than simpler ones. According to Schumacker and Lomax [19] , a root mean square error of approximation ≤0.05 indicates good model fit.
Survival analyses were made with the Kaplan-Meier survival curve and the Cox proportional hazard model. Patients were followed until death or kidney transplantation, and no other censoring was applied. The univariate and multivariate Cox regression analyses are presented as hazard ratio [HR; 95% confidence intervals (CIs)]. Proportionality and linearity assumptions of the exposure and confounders were verified by inspection of the Schoenfeld residuals. Given that 93 patients (30%) were referred to us with CKD stage 5 about to start dialysis, we did not consider dialysis as an end point or censoring. Sensitivity analyses contemplated, however, the exclusion of these individuals. Nonlinear associations between the MIS and death were assessed using fractional polynomials and restricted cubic splines. Variance inflation factors (VIF) were used to assess collinearity between independent variables. Overall MIS prediction was compared with means of Akaike information criterion [20] with that of albumin alone and of Charlson score. Additional analyses tried to identify suitable mortality and PEW prediction cutoffs in our patient population by means of receiving operator characteristics (ROC) curves. Statistical analyses were performed using the statistical software SPSS version 13.0 (SPSS, Inc., Chicago, IL, USA) and STATA version 13.1 (Statacorp, TX, USA).
R E S U LT S
General characteristics of the patients General characteristics of the studied population are summarized in Table 1 . The main etiology of CKD was diabetes mellitus (129 patients; 43%), followed by hypertensive nephrosclerosis (73 patients; 24%), unknown etiologies (53 patients; 18%), chronic glomerulonephritis (19 patients; 6%) and other (26 patients; 9%). The distribution of MIS is shown in Figure 1 . Fifty-eight individuals (19%) presented a MIS >8.
Patient characteristics according to tertiles of the Malnutrition-Inflammation Score Table 1 describes general patient characteristics according to the tertiles of MIS. Across increasing tertiles, patients were more often women, and also had a lower GFR. Whereas albuminuria, phosphorus and PTH were increased, the levels of hemoglobin, triglycerides and leptin were incrementally reduced across increasing MIS tertiles. Acute phase reactants (i.e. a1-AGP, fibrinogen, ferritin and CRP) increased linearly across MIS categories. Additionally, there was a progressive worsening of all indicators of nutritional status analyzed (Table 2) .
Individual items of the Malnutrition-Inflammation Score
The descriptive statistics of individual items included in MIS and their contribution to the score are listed in Table 3 .
While decreased fat stores and signs of muscle wasting had the highest corrected item-total correlation, comorbidities and dietary intake had the lowest.
Structural equation models for MIS
Two structural equation models were fitted to our data assuming one or two latent variables that can be thought of as theoretical constructs. In the two latent variables model, an inflammatory and a malnutrition latent variable were assumed. The goodness-of-fit statistics showed better fit for the model with two latent variables in our analysis, supporting the hypothesis of a separate synergistic impact of the inflammatory and the malnutrition factor (Comparative Fit index 1.000 versus 0.912; root mean square error of approximation <0.001 (0-0.001) versus 0.089 (0.055-0.126), two versus one latent variable model, respectively). Figure 2 shows the pathways, standardized coefficients and correlations for the two latent variable models. The covariance between the latent variable malnutrition and MIS was significantly different from zero (12.41, P < 0.001) and the correlation was 0.850. Similarly, the covariance and correlation between the latent variable inflammation and MIS was 7.44 and 0.514 (P < 0.001), respectively.
Association of the Malnutrition-Inflammation Score with outcomes
During a follow-up of median 30 (18-37) months, 71 deaths were registered due to acute myocardial infarction (n = 17), sudden cardiac death (n = 6), stroke (n = 7), congestive heart failure (n = 2), cardiac arrhythmia (n = 1), aortic artery disease (n = 2), infectious disease (n = 26), respiratory failure (n = 4), gastrointestinal bleeding (n = 2), gastrointestinal cancer (n = 2), traumatic brain injury (n = 1) and polytrauma (n = 1). The crude total mortality rate was 101/1000 patient- (Figure 3) . By using univariate and multivariate Cox proportional hazards models, we compared the prognostic power of MIS, as continuous or categorical variable (Table 4) . In crude models, MIS was associated with a higher hazard for deaths. Higher MIS was associated with all-cause mortality when analyzed in unadjusted Cox models as presented in a spline curve (Figure 4 ). These associations remained significant after adjustments for age, sex and GFR, and MIS remained associated with mortality also after further adjustments for comorbidities, smoking status and albuminuria ( Table 4) Table S1 ), we performed ROC analyses to estimate the best cutoffs in our material to predict death or the presence of PEW (depicted as alterations in, at least, two of the categories proposed by the ISRNM criteria [1] ; number of positive cases = 65). Our analysis showed that an MIS >3 offered the highest sensitivity for both outcomes, but specificity was in general low. On the other hand, a MIS >8 offered the best specificity in both cases, but the lowest sensitivity. 
D I S C U S S I O N
To the best of our knowledge, this is the first study to evaluate MIS in patients with nondialyzed CKD stages 3-5. We report data indicating that MIS is a useful tool to concurrently assess nutritional and inflammatory biomarkers, the essence of the PEW syndrome, and to predict mortality risk in this patient population.
The commonness of undernutrition and inflammation, and consequently its corollary, PEW, justifies the development of simple and easy-to-use instruments to assess this complex interplay. MIS was originally developed in HD patients [5] and was later applied and validated in patients undergoing other modalities of renal replacement therapy [5, [21] [22] [23] . The results of our study show that MIS is a useful diagnostic and prognostic assessment tool also in CKD patients. We assessed the applicability of MIS as a surrogate of PEW by testing its correlation with a range of MIS-independent and accepted markers of nutritional and inflammatory status. The hypothesis that MIS meaningfully reflects PEW was further confirmed by a structural equation model, which showed a better goodness of fit for the model assuming these two latent variables (concurrently assessing malnutrition and inflammation surrogates). This method allows simultaneous modeling of multiple layers of independent-and dependent-variable constructs, which is relevant given the intricate interplay of the variables considered.
Another important finding in our study is the direct association between MIS and mortality risk, extending its prognostic usefulness [5] [6] [7] [8] [9] to nondialyzed CKD patients. CKD patients with signs of PEW have increased morbidity and mortality, and although the pathophysiologic pathways underlying this association are not completely understood, a variety of nutritional, metabolic, hormonal and immunologic derangements present in those with PEW are assumed to have a significant role in the increased risk for infections and cardiovascular events in this patient population [1, 3, 24, 25] . Along with the above-mentioned factors, anemia also has a potential role in the increased mortality rate of patients with PEW, and decreasing hemoglobin levels and erythropoietin resistance are associated with cardiovascular events, hospital admission and death [26] [27] [28] [29] [30] [31] . There is a strong correlation between anemia, erythropoietin sensitivity and PEW [32] [33] [34] , which is possibly mediated by inflammation [35, 36] . Our data are in line with this by showing that across the MIS tertiles while hemoglobin decreases there is a progressive increment in ferritin levels; a pattern expected in the acute phase response, not in the context of iron deficiency [35] .
Very few studies, using SGA, have estimated the prevalence of PEW in nondialyzed CKD stages 3-5 to range between 9 and 18% [37] [38] [39] . In dialysis patients, an MIS >8 has at times been considered as a cutoff for malnutrition, and using this cutoff, our analysis shows a 19% prevalence of malnutrition. Typically, MIS tends to include a larger proportion of malnutrition by considering hypoalbuminemia in its scoring [40] . Whether this cutoff applies also in nondialyzed CKD we cannot assure, as in our analyses it yielded a low sensitivity. Nevertheless, due to our somewhat limited sample size, further more powered materials should ideally address this issue. Our study has the advantage of a careful characterization of patients in terms of nutritional and inflammatory indicators. Use of structural equation modeling also allowed us to analyze the complex network between these variables and their association with MIS, which increases the reliability of our analysis and supports the biological relevance of the assumed model. However, several limitations should be considered: patients from a single center were enrolled, and although the largest of its kind to date, confirmation in other materials is warranted and results are not to be generalized without further considerations. Because unwillingness to participate was an exclusion criterion, this may also be understood as a potential source of bias. However, we believe that it is unlikely that this would have qualitatively changed our results. In summary, the results of the current study suggest that MIS is a useful tool to assess the presence and implications of PEW in CKD patients.
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